Szilvia Veszelka

Temesvári Blvd. 62
Szeged, CS 6726, Hungary

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 42 publications

The histone deacetylase inhibitor, suberoylanilide hydroxamic acid, restores blood-brain barrier integrity in a human stem cell-based model of ischaemic stroke.

The histone deacetylase inhibitor, suberoylanilide hydroxamic acid, restores blood-brain barrier integrity in a human stem cell-based model of ischaemic stroke.

Journal: British journal of pharmacology

Published: September 24, 2025

The impact of the novel σ1 receptor ligand (S)-L1 on brain endothelial cells and cerebrovascular reactivity challenged by ischemia.

The impact of the novel σ1 receptor ligand (S)-L1 on brain endothelial cells and cerebrovascular reactivity challenged by ischemia.

Journal: European journal of pharmacology

Published: February 13, 2025

Nicotinamide derivatives protect the blood-brain barrier against oxidative stress.

Nicotinamide derivatives protect the blood-brain barrier against oxidative stress.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: January 28, 2025

Alanine and glutathione targeting of dopamine- or ibuprofen-coupled polypeptide nanocarriers increases both crossing and protective effects on a blood-brain barrier model.

Alanine and glutathione targeting of dopamine- or ibuprofen-coupled polypeptide nanocarriers increases both crossing and protective effects on a blood-brain barrier model.

Journal: Fluids and barriers of the CNS

Published: September 26, 2024

PepH3-modified nanocarriers for delivery of therapeutics across the blood-brain barrier.

PepH3-modified nanocarriers for delivery of therapeutics across the blood-brain barrier.

Journal: Fluids and barriers of the CNS

Published: August 30, 2024

Synergistic induction of blood-brain barrier properties.

Synergistic induction of blood-brain barrier properties.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: May 15, 2024

Editorial: Women in CNS drug delivery: 2022-2024.

Editorial: Women in CNS drug delivery: 2022-2024.

Journal: Frontiers in drug delivery

Published: March 14, 2024

Lab-on-a-chip models of the blood-brain barrier: evolution, problems, perspectives.

Lab-on-a-chip models of the blood-brain barrier: evolution, problems, perspectives.

Journal: Lab on a chip

Published: February 14, 2024

Targeting Human Endothelial Cells with Glutathione and Alanine Increases the Crossing of a Polypeptide Nanocarrier through a Blood-Brain Barrier Model and Entry to Human Brain Organoids.

Targeting Human Endothelial Cells with Glutathione and Alanine Increases the Crossing of a Polypeptide Nanocarrier through a Blood-Brain Barrier Model and Entry to Human Brain Organoids.

Journal: Cells

Published: November 24, 2022

Soluplus® promotes efficient transport of meloxicam to the central nervous system via nasal administration.

Soluplus® promotes efficient transport of meloxicam to the central nervous system via nasal administration.

Journal: International journal of pharmaceutics

Published: October 20, 2022

Effects of Hydroxypropyl-Beta-Cyclodextrin on Cultured Brain Endothelial Cells.

Effects of Hydroxypropyl-Beta-Cyclodextrin on Cultured Brain Endothelial Cells.

Journal: Molecules (Basel, Switzerland)

Published: September 26, 2022

Cellular Therapy Using Epitope-Imprinted Composite Nanoparticles to Remove α-Synuclein from an In Vitro Model.

Cellular Therapy Using Epitope-Imprinted Composite Nanoparticles to Remove α-Synuclein from an In Vitro Model.

Journal: Cells

Published: July 21, 2022

Showing 1-12 of 42

Last Updated: 09/26/2026